Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy

S K Kritas, G Ronconi, Al Caraffa, C E Gallenga, R Ross, P Conti

Article ID: 4499
Vol 34, Issue 1, 2020
DOI: https://doi.org/10.23812/20-Editorial-Kritas
Received: 10 March 2020; Accepted: 10 March 2020; Available online: 10 March 2020; Issue release: 10 March 2020

Abstract

Coronavirus can cause respiratory syndrome which to date has affected about twelve thousand individuals, especially in China. Coronavirus is interspecies and can also be transmitted from man to man, with an incubation ranging from 1 to 14 days. Human coronavirus infections can induce not only mild to severe respiratory diseases, but also inflammation, high fever, cough, acute respiratory tract infection and dysfunction of internal organs that may lead to death. Coronavirus infection (regardless of the various types of corona virus) is primarily attacked by immune cells including mast cells (MCs), which are located in the submucosa of the respiratory tract and in the nasal cavity and represent a barrier of protection against microorganisms. Viral activate MCs release early inflammatory chemical copounds including histamine and protease; while late activation provoke the generation of pro-inflammatory IL-1 family members including IL-1, IL-6 and IL-33. Here, we propose for the first time that inflammation by coronavirus maybe inhibited by anti-inflammatory cytokines belonging to the IL-1 family members.


Keywords

Coronavirus;immunity;infection;inflammation;mast cell


References

Supporting Agencies



Copyright (c) 2020 S K Kritas, G Ronconi, Al Caraffa, C E Gallenga, R Ross, P Conti




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).